Towards Effective CAIX-targeted Radionuclide and Checkpoint Inhibition Combination Therapy for Advanced Clear Cell Renal Cell Carcinoma
Simone Caroline Kleinendorst, Egbert Oosterwijk, Janneke D.M. Molkenboer‐Kuenen, Cathelijne Frielink, Gerben M. Franssen, Daan F. Boreel, Giulia Tamborino, Manon Gloudemans, M. Hendrikx, Dennis Kroon, Jopp Hillen, Johan Bussink, Stijn Muselaers, Peter Mulders, M. W. Konijnenberg, , Sandra Heskamp
This study investigates the combination of targeted radionuclide therapy and immune checkpoint inhibitors for advanced clear cell renal cell carcinoma, showing enhanced therapeutic outcomes and immune microenvironment changes.
Theranostics · Jan 1, 2024Peer-reviewedCancer Biology